References
Murray I, Chittenden SJ, Denis-Bacelar AM, Hindorf C, Parker CC, Chua S, et al. The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2017; https://doi.org/10.1007/s00259-017-3744-y.
Lin C, Bradshaw TJ, Perk TG, Harmon S, Eickhoff J, Jallow N, et al. Repeatability of quantitative 18F-NaF PET: a multicenter study. J Nucl Med. 2016;57:1872–9.
Laffon E, Lamare F, de Clermont H, Burger IA, Marthan R. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak. Eur Radiol. 2014;24:1964–70.
Caubet O, Meunier V, Marthan R, Laffon E. Early assessment of treatment response in Takayasu arteritis: an 18FDG PET procedure. Clin Nucl Med. 2016;41:743–5.
Lodge MA. Repeatability of SUV in oncologic 18F-FDG PET. J Nucl Med. 2017;58:523–32.
Etchebehere EC, Araujo JC, Fox PS, Swanston NM, Macapinlac HA, Rohren EM. Prognostic factors in patients treated with 223Ra: the role of skeletal tumor burden on baseline 18F-fluoride PET/CT in predicting overall survival. J Nucl Med. 2015;56:1177–84.
JCGM. Evaluation of measurement data - guide to the expression of uncertainty in measurement. 2008; www.bipm.org, Sept 2008.
Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney Y, et al. The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med. 2012;53:1175–84.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Research involving human participants and/or animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
The ethics committees of our teaching hospitals approved this retrospective study and the requirement to obtain further informed consent of the example patient was waived.
Rights and permissions
About this article
Cite this article
Laffon, E., de Clermont, H., Marthan, R. et al. On the 18F–fluoride PET imaging quantification to predict 223Ra-dichloride treatment response. Eur J Nucl Med Mol Imaging 45, 318–320 (2018). https://doi.org/10.1007/s00259-017-3868-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-017-3868-0